ASA On Baby Dove Microbiome Claims: Unilever’s Evidence Comes Up Short
Unilever’s in vitro and clinical studies examining the effects of glycerol, an ingredient in Baby Dove wash and lotion, were inadequate to substantiate microbiome claims as consumers are likely to understand them, according to a 13 January decision from the UK-based Advertising Standards Authority.
You may also be interested in...
US Plaintiffs Branching From Natural To Clean-Type Claims, Attorneys Warn At PCPC Virtual Summit
Are botanical claims equivalent to natural claims? Can hair truly be repaired? What constitutes “oil-free”? Such are the questions raised in growing litigation against cosmetic product companies under consumer protection statutes around the US, Conkle, Kremer & Engel attorneys say.
ICCR’s Growing Membership Ensures Diverse Cosmetics Regulatory Perspectives – PCPC
South Korea’s Ministry of Food and Drug Safety and Taiwan’s Food and Drug Administration will transition from ICCR observers to full members, joining regulatory authorities from the US, Europe, Japan, Canada and Brazil. PCPC’s Francine Lamoriello, EVP of global affairs, discusses.
L’Oreal’s Microbiome Explorations Lead To Micreos Deal For Next-Gen Antibacterial
“We expect this partnership to be groundbreaking,” says Mark Offerhaus, CEO of Micreos, which will provide L’Oreal with its proprietary endolysin, which selectively destroys microorganisms associated with skin problems while leaving beneficial bacteria intact.